USPatentGranted
B2

Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

Granted 31 May 2005 · 4 office actions

Current assignee: Maxim Pharmaceuticals, Inc. · originally Cytovia, Inc.

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Sui Xiong Cai, Richard Storer, Songchun Jiang, John Drewe +2 · Examiner: D. Margaret Seaman · AU 1625 · TC 1600

Life of the patent

4 dated events
⤢ drag to zoomJul 2001Jan 2002Jul 2002Jan 2003Jul 2003Jan 2004Jul 2004Jan 2005Jul 2005Prosecution
Prosecutionhover for detail · click to open

Abstract

The present invention is directed to substituted coumarins and quinolines and analogs thereof, represented by the general Formula I: [structure] wherein A, B, X, Y, and Z are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention can be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

Claims

20 · 3 independent · depth 4
1234567891011121314151617181920
20 granted claims

Classifications

16 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C07D311/04
USPC · US Patent Classification
546/144514/307514/444514/291549/399514/314514/456549/173514/312546/167546/157546/283.1549/13548/517514/422

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
3.0 y
1,111 days filing → grant
Office actions
2
after a restriction
Responses
2
2 RCE
Examiner
D. Margaret Seaman
art unit 1625 · TC 1600
Citations: 62 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

2 priority documents
Priority
16 May 2001
earliest claimed
›Priority documents — 2
TypeDocumentDate
provisionalUS 60290978 0016 May 2001
related publicationUS 20030114485 A119 Jun 2003

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock